Literature DB >> 11971091

Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes.

M D Boska1, K M A Welch, P B Barker, J A Nelson, L Schultz.   

Abstract

BACKGROUND: Previous single voxel (31)P MRS pilot studies of migraine patients have suggested that disordered energy metabolism or Mg(2+) deficiencies may be responsible for hyperexcitability of neuronal tissue in migraine patients. These studies were extended to include multiple brain regions and larger numbers of patients by multislice (31)P MR spectroscopic imaging.
METHODS: Migraine with aura (MWA), migraine without aura (MwoA), and hemiplegic migraine patients were studied between attacks by (31)P MRS imaging using a 3-T scanner.
RESULTS: Results were compared with those in healthy control subjects without headache. In MwoA, consistent increases in phosphodiester concentration [PDE] were measured in most brain regions, with a trend toward increase in [Mg(2+)] in posterior brain. In MWA, phosphocreatine concentration ([PCr]) was decreased to a minor degree in anterior brain regions and a trend toward decreased [Mg(2+)] was observed in posterior slice 1, but no consistent changes were found in phosphomonoester concentration [PME], [PDE], inorganic phosphate concentration ([Pi]), or pH. In hemiplegic migraine patients, [PCr] had a tendency to be lower, and [Mg(2+)] was significantly lower than in the posterior brain regions of control subjects. Trend analysis showed a significant decrease of brain [Mg(2+)] and [PDE] in posterior brain regions with increasing severity of neurologic symptoms.
CONCLUSIONS: Overall, the results support no substantial or consistent abnormalities of energy metabolism, but it is hypothesized that disturbances in magnesium ion homeostasis may contribute to brain cortex hyperexcitability and the pathogenesis of migraine syndromes associated with neurologic symptoms. In contrast, migraine patients without a neurologic aura may exhibit compensatory changes in [Mg(2+)] and membrane phospholipids that counteract cortical excitability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971091     DOI: 10.1212/wnl.58.8.1227

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  (1)H-MRS of brain metabolites in migraine without aura: absolute quantification using the phantom replacement technique.

Authors:  Harmen Reyngoudt; Yves De Deene; Benedicte Descamps; Koen Paemeleire; Eric Achten
Journal:  MAGMA       Date:  2010-08-13       Impact factor: 2.310

Review 2.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 3.  Migraine changes the brain: neuroimaging makes its mark.

Authors:  Till Sprenger; David Borsook
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

Review 4.  Ophthalmologic migraine.

Authors:  Robert F Saul
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

5.  Prophylactic Therapy for Migraine.

Authors:  Shazia Afridi; Holger Kaube
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

6.  Newly developed Mg2+-selective fluorescent probe enables visualization of Mg2+ dynamics in mitochondria.

Authors:  Yutaka Shindo; Tomohiko Fujii; Hirokazu Komatsu; Daniel Citterio; Kohji Hotta; Koji Suzuki; Kotaro Oka
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

7.  Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study.

Authors:  Alireza Baratloo; Sahar Mirbaha; Hossein Delavar Kasmaei; Pooya Payandemehr; Ahmed Elmaraezy; Ahmed Negida
Journal:  Korean J Pain       Date:  2017-06-30

8.  The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines.

Authors:  Mahnaz Rezaei Kelishadi; Amirmansour Alavi Naeini; Fariborz Khorvash; Gholamreza Askari; Zahra Heidari
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 9.  The Role of Metabolism in Migraine Pathophysiology and Susceptibility.

Authors:  Olivia Grech; Susan P Mollan; Benjamin R Wakerley; Daniel Fulton; Gareth G Lavery; Alexandra J Sinclair
Journal:  Life (Basel)       Date:  2021-05-01

Review 10.  Role of neuroimaging in our understanding of the pathogenesis of primary headaches.

Authors:  Laszlo Mechtler
Journal:  Curr Pain Headache Rep       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.